Nanobiotechnology: A New Frontier for Brain Disorders
Funding
Conflicts of Interest
References
- Matilla-Dueñas, A.; Corral-Juan, M.; Rodríguez-Palmero Seuma, A.; Vilas, D.; Ispierto, L.; Morais, S.; Sequeiros, J.; Alonso, I.; Volpini, V.; Serrano-Munuera, C.; et al. Rare Neurodegenerative Diseases: Clinical and Genetic Update. Adv. Exp. Med. Biol. 2017, 1031, 443–496. [Google Scholar] [CrossRef] [PubMed]
- Dong, X. Current Strategies for Brain Drug Delivery. Theranostics 2018, 5, 1481–1493. [Google Scholar] [CrossRef] [PubMed]
- Alexander, A.; Agrawal, M.; Uddin, A.; Siddique, S.; Shehata, A.M.; Shaker, M.A.; Ata Ur Rahman, S.; Abdul, M.I.M.; Shaker, M.A. Recent expansions of novel strategies towards the drug targeting into the brain. Int. J. Nanomed. 2019, 30, 5895–5909. [Google Scholar] [CrossRef] [PubMed]
- Picone, P.; Palumbo, F.S.; Federico, S.; Pitarresi, G.; Adamo, G.; Bongiovanni, A.; Chaves, A.; Cancemi, P.; Muccilli, V.; Giglio, V.; et al. Nano-structured myelin: New nanovesicles for targeted delivery to white matter and microglia, from brain-to-brain. Mater. Today Bio 2021, 12, 100146. [Google Scholar] [CrossRef] [PubMed]
- Sharma, G.; Sharma, A.R.; Lee, S.S.; Bhattacharya, M.; Nam, J.S.; Chakraborty, C. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. Int. J. Pharm. 2019, 25, 360–372. [Google Scholar] [CrossRef] [PubMed]
- Picone, P.; Sabatino, M.A.; Ditta, L.A.; Amato, A.; San Biagio, P.L.; Mulè, F.; Giacomazza, D.; Dispenza, C.; Di Carlo, M. Nose-to-brain delivery of insulin enhanced by a nanogel carrier. J. Contr. Release 2018, 28, 23–36. [Google Scholar] [CrossRef] [PubMed]
- Picone, P.; Nuzzo, D. Biofabrication of nanovesicles for brain diseases. Neural Regen. Res. 2023, 18, 525–526. [Google Scholar] [CrossRef]
- Gandhi, H.; Sharma, A.K.; Mahant, S.; Kapoor, D.N. Recent advancements in brain tumor targeting using magnetic nanoparticles. Ther. Deliv. 2020, 11, 97–112. [Google Scholar] [CrossRef] [PubMed]
- D’Agata, F.; Ruffinatti, F.A.; Boschi, S.; Stura, I.; Rainero, I.; Abollino, O.; Cavalli, R.; Guiot, C. Magnetic Nanoparticles in the Central Nervous System: Targeting Principles, Applications and Safety Issues. Molecules 2017, 21, 9. [Google Scholar] [CrossRef] [PubMed]
- Picone, P.; Porcelli, G.; Bavisotto, C.C.; Nuzzo, D.; Galizzi, G.; San Biagio, P.L.; Bulone, D.; Di Carlo, M. Synaptosomes: New vesicles for neuronal mitochondrial transplantation. J. Nanobiotechnol. 2021, 6, 19. [Google Scholar] [CrossRef] [PubMed]
- Picone, P.; Nuzzo, D. Promising Treatment for Multiple Sclerosis: Mitochondrial Transplantation. Int. J. Mol. Sci. 2022, 23, 2245. [Google Scholar] [CrossRef] [PubMed]
- Rufino-Ramos, D.; Albuquerque, P.R.; Carmona, V.; Perfeito, R.; Nobre, R.J.; Pereira de Almeida, L. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases. J. Control. Release 2017, 28, 247–258. [Google Scholar] [CrossRef] [PubMed]
- Croese, T.; Furlan, R. Extracellular vesicles in neurodegenerative diseases. Mol. Asp. Med. 2018, 60, 52–61. [Google Scholar] [CrossRef] [PubMed]
- Soliman, H.M.; Ghonaim, G.A.; Gharib, S.M.; Chopra, H.; Farag, A.K.; Hassanin, M.H.; Nagah, A.; Emad-Eldin, M.; Hashem, N.E.; Yahya, G.; et al. Exosomes in Alzheimer’s Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics. Int. J. Mol. Sci. 2021, 6, 10794. [Google Scholar] [CrossRef] [PubMed]
- Picone, P.; Nuzzo, D.; Giacomazza, D.; Di Carlo, M. β-Amyloid Peptide: The Cell Compartment Multi-faceted Interaction in Alzheimer’s disease. Neurotox. Res. 2020, 37, 250–263. [Google Scholar] [CrossRef] [PubMed]
- Jonavičė, U.; Romenskaja, D.; Kriaučiūnaitė, K.; Jarmalavičiūtė, A.; Pajarskienė, J.; Kašėta, V.; Tunaitis, V.; Malm, T.; Giniatulin, R.; Pivoriūnas, A. Extracellular Vesicles from Human Teeth Stem Cells Trigger ATP Release and Promote Migration of Human Microglia through P2X4 Receptor/MFG-E8-Dependent Mechanisms. Int. J. Mol. Sci. 2021, 11, 10970. [Google Scholar] [CrossRef] [PubMed]
- Nuzzo, D.; Picone, P. Multiple Sclerosis: Focus on Extracellular and Artificial Vesicles, Nanoparticles as Potential Therapeutic Approaches. Int. J. Mol. Sci. 2021, 22, 8866. [Google Scholar] [CrossRef] [PubMed]
- Lico, C.; Tanno, B.; Marchetti, L.; Novelli, F.; Giardullo, P.; Arcangeli, C.; Pazzaglia, S.; Podda, M.S.; Santi, L.; Bernini, R.; et al. Tomato Bushy Stunt Virus Nanoparticles as a Platform for Drug Delivery to Shh-Dependent Medulloblastoma. Int. J. Mol. Sci. 2021, 29, 10523. [Google Scholar] [CrossRef] [PubMed]
- Varlamova, E.G.; Turovsky, E.A.; Babenko, V.A.; Plotnikov, E.Y. The Mechanisms Underlying the Protective Action of Selenium Nanoparticles against Ischemia/Reoxygenation Are Mediated by the Activation of the Ca2+ Signaling System of Astrocytes and Reactive Astrogliosis. Int. J. Mol. Sci. 2021, 26, 12825. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Picone, P. Nanobiotechnology: A New Frontier for Brain Disorders. Int. J. Mol. Sci. 2022, 23, 9603. https://doi.org/10.3390/ijms23179603
Picone P. Nanobiotechnology: A New Frontier for Brain Disorders. International Journal of Molecular Sciences. 2022; 23(17):9603. https://doi.org/10.3390/ijms23179603
Chicago/Turabian StylePicone, Pasquale. 2022. "Nanobiotechnology: A New Frontier for Brain Disorders" International Journal of Molecular Sciences 23, no. 17: 9603. https://doi.org/10.3390/ijms23179603